Ex Parte Steiner et al - Page 2



         Appeal No. 2003-1169                                                       
         Application 09/879,888                                                     


              (i)  an effective amount of nitrogen-containing heterocyclic          
         compound having two or more heteroatoms, wherein said compound             
         has a substituent —C(W)-C(Y)- which is attached to a nitrogen              
         atom of the heterocyclic ring,                                             
              wherein W and Y are independently selected from the group             
         consisting of O, S, CH2 and H2, and wherein said compound is               
         additionally substituted with a ester or amide substituent                 
         attached to any atom of the heterocyclic ring other than said              
         nitrogen atom,                                                             
              provided that said ester or amide substituent is not an N-            
         oxide of an ester or amide and further provided that said amide            
         substituent is linked to the heterocyclic ring with a carbon-              
         carbon bond;                                                               
              (ii)  a second compound for treating alopecia or promoting            
         hair growth; and                                                           
              (iii)  a pharmaceutically acceptable carrier.                         

              33.  A pharmaceutical composition which comprises:                    
              (i)  an effective amount of a nitrogen-containing                     
         heterocyclic compound having two or more heteroatoms;                      
              wherein said compound has a substituent –C(W)-C(Y)- which is          
         attached to a nitrogen atom of the heterocyclic ring, wherein W            
         and Y are independently selected from the group consisting of O,           
         S, CH2, and H2, and                                                        
              wherein said compound is additionally substituted with an             
         ester or amide substituent attached to any atom of the                     
         heterocyclic ring other than said nitrogen atom,                           
              provided that said ester or amide substituent is not an N-            
         oxide of an ester or amide and further provided that said amide            
         substituent is linked to the heterocyclic ring with a carbon-              
         carbon bond; and                                                           
              (ii)  a pharmaceutically acceptable carrier.                          


                                       2                                            






Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007